CONTENTS:
1. Epidemiology of dementia and Alzheimer""s disease. The Cuban experience
2. Early-onset Alzheimer""s disease. From genes to proteins
3. Genetics risk factors for late-onset Alzheimer""s disease
4. Genetics of Alzheimer""s disease in Cuba
5. Association of genetic risk factors in Alzheimer""s disease
6. Immune markers in Alzheimer""s disease
7. Neuropsychological assessment in Alzheimer""s disease diagnosis
8. Psychometric evaluation and apolipoprotein E genotyping
9. Brain electrical activity mapping, disease staging and apolipoprotein E genotyping in senile dementia
10. Changes in brain hemodynamic parameters associated with disease staging and apolipoprotein E genotyping in patients with senile dementia
11. Apolipoprotein E-related blood pressure parameters in senile dementia
12. Apolipoprptein E genotype-related serum apolipoprotein E and lipid levels in Alzheimer""s disease
13. Blood histamine levels, brain hemodynamic parameters and risk factors in Alzheimer""s disease and vascular dementia
14. The application of CT scanning to the diagnosis of Alzheimer""s disease
15. Long-term potentiation in animal models of dementia
16. Tau protein levels in cerebrospinal fluid and apolipoprotein E genotyping in differential diagnosis of dementia
17. Antiapoptopic effects of CDP-choline in a combined animal model of hippocampal neurodegeneration
18. Genotype-specific microglial reponse in cell culture systems for the identification of novel therapeutic compounds in Alzheimer""s disease and neuroimmune disorders
19. The usefulness of neurotrophic factors for treatment of Alzheimer""s disease
20. Alzheimer""s disease: from cholinergic hypothesis to cholinergic treatment
21. Alzheimer""s disease: pharmacoeconomics, glutamate-induced neurodegeneration and preventive strategies
22. Cognitive and affective interventions to maximize abilities and adjusment in dementia
23. Creating supportive environments for persons with dementia
24. The impact of Alzheimer""s disease on the family
25. Neurorehabilitation of central nervous system disorders and dementia
26. Evolution of senescence: Cellular aging, apoptosis, immune surveillance and tumor development
27. The aged monkey: electrophysiological follow-up of nerve growth factors effects
28. Preclinical studies with nerve growth factor in Cuba
29. Enhanced cognitive performance in aged memory-impaired rats treated with selective muscarinic antagonist
